Publication Name	World Journal of Clinical Oncology
Manuscript ID	54279
Country	United States

Received	2020-01-21 21:44
Peer-Review Started	2020-01-17 15:06
To Make the First Decision
Return for Revision	2020-03-05 22:02
Revised	2020-05-21 17:25
Second Decision	2020-06-23 08:05
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2020-06-27 20:54
Articles in Press	2020-06-27 20:54
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2020-07-29 06:53
Publish the Manuscript Online	2020-08-21 01:38

ISSN	2218-4333 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Case Report
Article Title	Concurrent renal cell carcinoma and hematologic malignancies: Nine case reports
Manuscript Source	Unsolicited Manuscript
All Author List	Lisa BE Shields and Arash Rezazadeh Kalebasty
ORCID	Author(s) ORCID Number Lisa BE Shields http://orcid.org/0000-0002-1526-4063 Arash Rezazadeh Kalebasty http://orcid.org/0000-0002-1526-4062
Funding Agency and Grant Number
Corresponding Author	Arash Rezazadeh Kalebasty, MD, Doctor, Doctor, Norton Cancer Institute, Norton Healthcare, 315 East Broadway, Louisville, KY 40202, United States. arez@uci.edu
Key Words	Oncology; Renal cell cancer; Hematologic malignancy; Lymphoma; Immune system; Immunotherapy
Core Tip	Renal cell carcinoma (RCC) and hematologic malignancies (HM) in the same patient is rare. We report the common characteristics of 9 patients diagnosed with concurrent RCC and HM and their clinical course and treatment response. None of the patients was treated with cytotoxic chemotherapy or radiation between the diagnosis of RCC and HM. Several features in our series strengthen the immune dysregulation theory as the likely mechanism. Long-term medical surveillance is warranted when a patient is diagnosed with RCC or HM. Clinicians should be aware that either of these conditions may be diagnosed first or they may be diagnosed simultaneously.
Publish Date	2020-08-21 01:38
Citation	Shields LBE, Kalebasty AR. Concurrent renal cell carcinoma and hematologic malignancies: Nine case reports. World J Clin Oncol 2020; 11(8): 644-654
URL	https://www.wjgnet.com/2218-4333/full/v11/i8/644.htm
DOI	https://dx.doi.org/10.5306/wjco.v11.i8.644

Full Article (PDF)	WJCO-11-644.pdf
Full Article (Word)	WJCO-11-644.docx
CARE Checklist–2016	54279-CARE-Checklist–2016-revision.tiff
Manuscript File	54279-Review.doc
Answering Reviewers	54279-Answering reviewers.pdf
Audio Core Tip	54279-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	54279-Conflict-of-interest statement.pdf
Copyright License Agreement	54279-Copyright license agreement.pdf
Signed Informed Consent Form(s) or Document(s)	54279-Informed consent statement.pdf
Peer-review Report	54279-Peer-review(s).pdf
Scientific Misconduct Check	54279-Bing-Dou Y-2.png
Scientific Misconduct Check	54279-Scientific misconduct check.pdf
Scientific Editor Work List	54279-Scientific editor work list.pdf
CrossCheck Report	54279-CrossCheck report.pdf